375 related articles for article (PubMed ID: 12359344)
1. The role of androgens and the androgen receptor in prostate cancer.
Debes JD; Tindall DJ
Cancer Lett; 2002 Dec; 187(1-2):1-7. PubMed ID: 12359344
[TBL] [Abstract][Full Text] [Related]
2. The role of the androgen receptor in the development and progression of prostate cancer.
Jenster G
Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor signaling in androgen-refractory prostate cancer.
Grossmann ME; Huang H; Tindall DJ
J Natl Cancer Inst; 2001 Nov; 93(22):1687-97. PubMed ID: 11717329
[TBL] [Abstract][Full Text] [Related]
4. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor involvement in the progression of prostate cancer.
Suzuki H; Ueda T; Ichikawa T; Ito H
Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
[TBL] [Abstract][Full Text] [Related]
6. Hormone treatment for prostate cancer: current issues and future directions.
Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367
[TBL] [Abstract][Full Text] [Related]
7. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.
Nguyen MM; Wang Z
Minerva Urol Nefrol; 2008 Mar; 60(1):15-29. PubMed ID: 18427432
[TBL] [Abstract][Full Text] [Related]
9. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer.
Young CY; Jatoi A; Ward JF; Blute ML
Curr Med Chem; 2004 Apr; 11(7):909-23. PubMed ID: 15078173
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
12. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
Kim Y; Kim J; Jang SW; Ko J
Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
[TBL] [Abstract][Full Text] [Related]
13. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
Arnold JT; Isaacs JT
Endocr Relat Cancer; 2002 Mar; 9(1):61-73. PubMed ID: 11914183
[TBL] [Abstract][Full Text] [Related]
15. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
Libertini SJ; Tepper CG; Rodriguez V; Asmuth DM; Kung HJ; Mudryj M
Cancer Res; 2007 Oct; 67(19):9001-5. PubMed ID: 17909000
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D3 action in androgen receptor regulation and prostate cancer.
Olshavsky NA; Groh EM; Comstock CE; Morey LM; Wang Y; Revelo MP; Burd C; Meller J; Knudsen KE
Oncogene; 2008 May; 27(22):3111-21. PubMed ID: 18084330
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.
Sommer A; Haendler B
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520
[TBL] [Abstract][Full Text] [Related]
18. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer.
Guo C; Yeh S; Niu Y; Li G; Zheng J; Li L; Chang C
Cancer Lett; 2017 Jul; 397():133-143. PubMed ID: 28323036
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in androgen-dependent PCa.
Zhu KC; Lu JJ; Xu XL; Sun JM
Front Biosci (Landmark Ed); 2013 Jan; 18(2):748-55. PubMed ID: 23276959
[TBL] [Abstract][Full Text] [Related]
20. Current thoughts on the role of the androgen receptor and prostate cancer progression.
Setlur SR; Rubin MA
Adv Anat Pathol; 2005 Sep; 12(5):265-70. PubMed ID: 16210922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
